Click image to view full size image
Lactobacillus rhamnosus is an anaerobic, acid-resistant, non-spore-forming Gram-positive probiotic. It possesses biological characteristics such as acid tolerance, bile salt resistance, and resistance to multiple antibiotics. Our product is made from Lactobacillus rhamnosus using a high-density cultivation fermentation process and low-temperature freeze-drying protection technology. The freeze-dried bacterial powder includes the strain, protective agent, and diluent carriers.
Exceptional Survival
Survival rate of ≥95% in gastric acid environment with pH 2.5.
Precise Colonization
Intestinal retention time of up to 14 days (compared to 3-5 days for regular strains).
Stability Guarantee
Live bacteria remain stable for 24 months at room temperature.
Pure Formula
Free from gluten, lactose, and artificial additives.
Our L. rhamnosus has been validated through 5 clinical trials and offers the following unique advantages
Improvement in antibiotic-associated diarrhea, reduction in the duration of rotavirus diarrhea in children, recurrent urinary tract infections (UTIs) in women and eczema symptoms in infants.
Industry-Leading Survival Technology
Third-generation microencapsulation + freeze-drying protection technology.
Full-Link Transparent Traceability
China Industrial Microorganism Strain Preservation Center CICC number, GMP standardized production, SGS third-party live bacteria count verification, and full-process temperature control.
Dietary Supplements-enteric-coated capsules / chewable tablets / powder: Improve antibiotic-associated diarrhea, relieve IBS symptoms.
Infant Nutrition-drops / formula milk: Prevent rotavirus diarrhea, alleviate infant eczema symptoms.
Women's Health Products-oral capsules / vaginal suppositories: Prevent urinary tract infection (UTI) recurrence, maintain vaginal microbiota balance.
Functional Foods-probiotic chocolate, ready-to-eat probiotic cereal bars.
Oral Care-probiotic toothpaste / mouthwash, oral probiotic lozenges.
Diarrhea Relief
89% improvement in antibiotic-associated diarrhea
1.8-day reduction in the duration of rotavirus diarrhea in children
Immune Enhancement
37% reduction in respiratory infections in children (8-week clinical study)
42% increase in vaccine antibody response
Women's Health
50% reduction in urinary tract infection recurrence
62% relief in bacterial vaginosis symptoms
Gut Barrier
35% increase in tight junction protein expression (ZO-1↑)
51% reduction in intestinal permeability (lactulose/mannitol ratio↓)
Skin Health
42% improvement in infant atopic dermatitis symptoms (12-week study)
|
Strain Name |
Lactobacillus rhamnosus NSL0401 |
|
Viable Count |
≥2×1011 CFU/g |
|
Moisture |
≤5.0% |
|
Packing |
500g/bag, 1kg/bag, 5kg/bag or customized |
Q1: What is Lactobacillus rhamnosus?
A: Scientific Definition: gram-positive probiotic, naturally inhabits human gut, acid-resistant (≥90% survival at pH3.0).
Q2: How soon will I see results?
A: Clinical Evidence: gut issue 2-4 weeks, immune modulation 8-12 weeks, acute diarrhea 24-48h improvement.
Q3: Is long-term use safe?
A: Research Conclusions: proven safe for 6-12 months continuous use, no adverse effects in 98% of users.
http://www.cgeprobiotics.com/